<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">J. Pharm. Pharm. Sci.</journal-id>
<journal-title-group>
<journal-title>Journal of Pharmacy &#x26; Pharmaceutical Sciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">J. Pharm. Pharm. Sci.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1482-1826</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">15609</article-id>
<article-id pub-id-type="doi">10.3389/jpps.2026.15609</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (<italic>Boswellia spp.</italic>): a preliminary <italic>in vitro</italic> study</article-title>
<alt-title alt-title-type="left-running-head">Javed et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/jpps.2026.15609">10.3389/jpps.2026.15609</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Javed</surname>
<given-names>Shamama</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salawi</surname>
<given-names>Ahmad</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moni</surname>
<given-names>Sivakumar S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ahsan</surname>
<given-names>Waquar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/53651"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khuwaja</surname>
<given-names>Gulrana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alam</surname>
<given-names>Md Shamsher</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sivadasan</surname>
<given-names>Durgaramani</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jabeen</surname>
<given-names>Aamena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aziabi</surname>
<given-names>Maram Yahya</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suwaydi</surname>
<given-names>Hind Mohammed</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alajam</surname>
<given-names>Taif Eassa M.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nammazi</surname>
<given-names>Amwaj Yahya Marwai</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kadumi</surname>
<given-names>Nourah Mohammed Ahmed</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Department of Pharmaceutics, College of Pharmacy, Jazan University</institution>, <city>Jazan</city>, <country country="SA">Saudi Arabia</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Health Research Centre, Jazan University</institution>, <city>Jazan</city>, <country country="SA">Saudi Arabia</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University</institution>, <city>Jazan</city>, <country country="SA">Saudi Arabia</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>College of Pharmacy, Jazan University</institution>, <city>Jazan</city>, <country country="SA">Saudi Arabia</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Waquar Ahsan, <email xlink:href="mailto:wmohammad@jazanu.edu.sa">wmohammad@jazanu.edu.sa</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-04-28">
<day>28</day>
<month>04</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>29</volume>
<elocation-id>15609</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>09</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>03</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>04</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Javed, Salawi, Moni, Ahsan, Khuwaja, Alam, Sivadasan, Jabeen, Aziabi, Suwaydi, Alajam, Nammazi and Kadumi.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Javed, Salawi, Moni, Ahsan, Khuwaja, Alam, Sivadasan, Jabeen, Aziabi, Suwaydi, Alajam, Nammazi and Kadumi</copyright-holder>
<license>
<ali:license_ref start_date="2026-04-28">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Frankincense (gum olibanum, <italic>Boswellia</italic> spp.) is an oleo-gum resin widely used in traditional medicine and cosmetics owing to the presence of volatile oils and pentacyclic triterpenic acids (boswellic acids) with reported anti-inflammatory and antioxidant properties.</p>
</sec>
<sec>
<title>Objectives</title>
<p>The aim of this study was to extract and characterize oil- and water-soluble fractions of frankincense resin, evaluate their antioxidant potential, and incorporate them into a stable water-in-oil (<italic>w/o</italic>) nourishing/antiaging cream.</p>
</sec>
<sec>
<title>Methods</title>
<p>Frankincense resin was ground and macerated separately in sweet almond oil and Madinah rosewater to yield oil and water infusions, respectively. Qualitative phytochemical tests and FT-IR spectroscopy were employed for the characterization of both extracts and final formulations. Antioxidant potential was assessed using the DPPH assay followed by the development of a <italic>w/o</italic> cream (beeswax:almond oil:rosewater base) using combined infusions, which was evaluated for pH, viscosity, phase separation, spreadability, and thermal stability.</p>
</sec>
<sec>
<title>Results</title>
<p>Phytochemical screening showed presence of triterpenoids and boswellic type functionalities predominantly in the oil infusion, whereas saponins and minor alkaloids were detected in the water infusion. In the DPPH assay, significant free radical scavenging activity was observed as sample 2 showed 71% inhibition at 343.46 &#xb1; 34.2&#xa0;&#x3bc;g/mL. The developed cream formulation showed good physical stability, acceptable pH and shear-thinning rheology.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>A stable, all-natural <italic>w/o</italic> cream formulation was developed incorporating combined oil- and water-soluble frankincense infusions. Future studies are warranted to perform quantitative chemical analysis, <italic>in vitro</italic> skin permeation, and formal skin safety testing to ensure uninform active content, good bioavailability and tolerability prior to clinical studies.</p>
</sec>
</abstract>
<kwd-group>
<kwd>antioxidant</kwd>
<kwd>
<italic>Boswellia</italic>
</kwd>
<kwd>boswellic acids</kwd>
<kwd>frankincense</kwd>
<kwd>gum olibanum</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, through project number: RG24-M01.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<equation-count count="1"/>
<ref-count count="60"/>
<page-count count="14"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>From time immemorial, plants and their derived products have played a fundamental role in meeting human needs, providing food, fragrances, flavors, dyes, and medicinal agents. Among the diverse array of plant-derived materials, aromatic resins have occupied an important position due to their multifaceted uses in medicine, perfumery, cosmetics and cultural rituals. One such resin, frankincense, also known as the gum olibanum, has been a valuable commodity for commerce and continues to be an important raw material in both traditional and modern applications [<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>]. Frankincense is a natural aromatic oleo-gum resin exuded from the bark of various species of the genus <italic>Boswellia</italic> (family Burseraceae). There are 25 species in the genus <italic>Boswellia</italic>. These species can be found in many places, including North Africa, Somalia (<italic>B</italic>. <italic>carterii</italic> and <italic>B</italic>. <italic>frereana</italic>), Ethiopia (<italic>B</italic>. <italic>papyrifera</italic> and <italic>B</italic>. <italic>rivae</italic>), India (<italic>B</italic>. <italic>serrata</italic>), the Arabian Peninsula (<italic>B</italic>. <italic>sacra</italic>), and Ethiopia (<italic>B</italic>. <italic>neglecta</italic>) [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. It is primarily obtained from making deliberate incisions into the bark of mature trees leading to a fragrant exudate to seep out and subsequently harden to afford tear-shaped resin droplets. The resin is composed mainly of three fractions: volatile oil, alcohol-soluble resin, and water-soluble gum. The volatile fraction is responsible for its characteristic aroma, while the resin fraction is rich in pentacyclic triterpenic acids, also referred to as boswellic acids, responsible for majority of its therapeutic properties. On the contrary, the gum fraction consists mainly of polysaccharides and water-soluble oligosaccharides [<xref ref-type="bibr" rid="B9">9</xref>].</p>
<p>Traditionally, frankincense has been widely employed in incense burning, religious rituals, and perfumery along with its use in alternative medicine systems, including Ayurveda, Traditional Chinese Medicine, and Arabian herbal practices. Its therapeutic potential is associated with a variety of biological activities such as antimicrobial, antioxidant, anti-inflammatory, and anti-proliferative properties [<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>]. The boswellic acids present in the resin includes &#x3b2;-boswellic acid, 11-keto-&#x3b2;-boswellic acid (KBA), and acetyl-11-keto-&#x3b2;-boswellic acid (AKBA) (<xref ref-type="fig" rid="F1">Figure 1</xref>). These acids are pentacyclic triterpenoids and have been reported to modulate inflammatory pathways by inhibiting the activity of pro-inflammatory enzymes, including 5-lipoxygenase and human leukocyte elastase [<xref ref-type="bibr" rid="B14">14</xref>]. The volatile fraction of frankincense contains a complex mixture of monoterpenes, diterpenes, and sesquiterpenes, contributing to its aroma and pharmacological effects.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Chemical structures of the major triterpenoids present in frankincense resin (<italic>Boswellia</italic> sp.). <bold>(A)</bold> &#x3b2;-boswellic acid; <bold>(B)</bold> 11-keto-&#x3b2;-boswellic acid; and <bold>(C)</bold> acetyl-11-keto-&#x3b2;-boswellic acid.</p>
</caption>
<graphic xlink:href="jpps-29-15609-g001.tif">
<alt-text content-type="machine-generated">Three labeled chemical structure diagrams show steroid compounds: panel A contains ursodeoxycholic acid, panel B contains chenodeoxycholic acid, and panel C contains tauroursodeoxycholic acid, each displaying characteristic ring systems and side chains.</alt-text>
</graphic>
</fig>
<p>The dermatological application of frankincense is supported by several mechanisms of action including new cell generation, enhancement of skin elasticity, reduction of depth and appearance of wrinkles, and by soothing dry and irritated skin [<xref ref-type="bibr" rid="B15">15</xref>]. These effects are results of its combined anti-inflammatory and antioxidant actions in addition to the ability of lipophilic terpenoids to penetrate stratum corneum resulting in the modulation of dermal processes. Moreover, frankincense extract is known to mitigate oxidative stress, a major contributor to skin aging, and therefore it may offer protection against photo-aging and environment-related skin damage. In a previous study, frankincense was reported to lower levels of intracellular cell adhesion molecule 1 (ICAM1) and interferon gamma-induced protein 10 (IP-10) <italic>in vitro</italic>, two significant inflammatory indicators causing unexpected skin sensitivity [<xref ref-type="bibr" rid="B16">16</xref>]. Frankincense-containing formula could alleviate itching and erythema in individuals with erythematous eczema and psoriasis, as evidenced by <italic>in vivo</italic> experiments confirming its anti-inflammatory action [<xref ref-type="bibr" rid="B17">17</xref>]. The gum resin extracted from <italic>B. serrata</italic> was utilized for a number of skin conditions. Through the TLR7/8 route, acetyl-11-keto-&#x3b2;-boswellic acid prevented dendritic cells from secreting cytokines <italic>in vitro</italic> and in a mouse model of imiquimod-induced psoriasis [<xref ref-type="bibr" rid="B18">18</xref>]. In extremely metastatic melanoma, boswellic acid acetate induced apoptosis and differentiation [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>].</p>
<p>From a formulation perspective, frankincense resin presents a unique opportunity owing to the complementary bioactive components present in both its water- and oil-soluble fractions. The water-soluble fraction is rich in polysaccharides which can contribute to skin hydration and support the skin barrier, while the oil-soluble fraction is rich in triterpenoids and essential oils which is well-suited for lipid-based delivery systems. Incorporating both fractions in a single topical formulation would lead to synergistic effects, and thereby could maximize the therapeutic potential of the resin. A water-in-oil (<italic>w/o</italic>) emulsion system is particularly suitable for such application as it can efficiently incorporate both lipophilic and hydrophilic components, providing an occlusive effect to reduce trans-epidermal water loss and enhance the stability of sensitive active ingredients [<xref ref-type="bibr" rid="B21">21</xref>].</p>
<p>Given these considerations, the present study was designed to prepare oil and water infusions of locally procured frankincense resin separately, characterize, and evaluate them for their antioxidant potential. This was followed by the development of <italic>w/o</italic> nourishing and anti-aging cream by incorporating both oil- and water-soluble infusions. Eventually, the physical, chemical, and stability parameters of the final formulation was evaluated to determine its suitability for cosmetic applications. By combining traditional folklore and modern analytical formulation techniques, this work was aimed to provide a scientific basis for the topical application of frankincense resin, potentially contributing to the development of effective and all-natural anti-aging skincare product.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Materials</title>
<p>Frankincense resin (gum olibanum) was procured locally from Elhekma company, Jazan, Saudi Arabia. Sweet almond oil (NOW&#xae; Solutions, Bloomingdale, IL, USA), used as lipophilic extraction medium, was purchased from a herbal pharmacy, while Madinah rosewater (Nada Rabee company, Madinah, Saudi Arabia) was obtained from a commercial supplier in Madinah, Saudi Arabia. Beeswax and other standard laboratory reagents were of analytical grade and were purchased from Sigma Aldrich (Steinheim, Germany). FT-IR Spectra were recorded using a SHIMADZU-IRSpirit-T spectrophotometer (Kyoto, Japan), while the UV-Vis spectrophotometric readings were recorded using a Cary 100 Bio UV-Vis spectrophotometer (Agilent Technologies, USA).</p>
</sec>
<sec id="s2-2">
<title>Preparation of frankincense infusions</title>
<p>The frankincense resin was first ground into fine powder using a household coffee grinder to increase the surface area for extraction. The powdered resin was then divided into two equal portions for the preparation of oil- and water-soluble infusions.</p>
<sec id="s2-2-1">
<title>Oil infusion</title>
<p>10&#xa0;g of finely powdered resin was suspended to 40&#xa0;g of sweet almond oil. The mixture was heated to 75&#xa0;&#xb0;C for 1&#xa0;h with occasional stirring to facilitate dissolution and then allowed to stand at room temperature for 3 days to allow maximum extraction of the lipophilic constituents. After the extraction period, mixture was filtered through muslin cloth to remove undissolved material, yielding the oil infusion of frankincense.</p>
</sec>
<sec id="s2-2-2">
<title>Water infusion</title>
<p>A separate 10&#xa0;g portion of powdered resin was suspended in 40&#xa0;g of Madinah rosewater and similar to the oil-infusion, the mixture was warmed to 75&#xa0;&#xb0;C for 1&#xa0;h and then left to stand at room temperature for 3 days. After the maceration process is over, the infusion was filtered to remove undissolved particles, yielding the water infusion.</p>
<p>Both the prepared infusions were stored in amber-colored bottles under refrigerated conditions until further use in phytochemical analysis, antioxidant assays, and formulation development.</p>
</sec>
</sec>
<sec id="s2-3">
<title>Qualitative phytochemical analyses</title>
<p>The oil and water infusions were subjected to standard qualitative chemical tests to preliminarily identify the major phytoconstituents of frankincense resin, particularly triterpenoids such as boswellic acids, along with other resinous and volatile components. Common chemical tests were employed in this study to determine authenticity and chemical nature of the resin. The intensity of reactions was recorded qualitatively as negative (&#x2212;), trace (&#x2b;/&#x2212;), present (&#x2b;), moderately present (&#x2b;&#x2b;), or strongly present (&#x2b;&#x2b;&#x2b;).</p>
<sec id="s2-3-1">
<title>Salkowski test (for triterpenoids and steroids)</title>
<p>A small amount of the resin infusion was dissolved in chloroform. A few drops of concentrated sulfuric acid were carefully added along the side of the test tube. A reddish-brown or golden-yellow color at the interface indicated the presence of triterpenoids or steroids [<xref ref-type="bibr" rid="B22">22</xref>].</p>
</sec>
<sec id="s2-3-2">
<title>Liebermann-Burchard test (for triterpenoids)</title>
<p>The infusions were dissolved in acetic anhydride. A drop or two of concentrated sulfuric acid were added slowly. A color change from pink to purple or blue-green indicated the presence of triterpenoids or sterols [<xref ref-type="bibr" rid="B23">23</xref>].</p>
</sec>
<sec id="s2-3-3">
<title>Acetylation test (for hydroxyl groups in boswellic acids)</title>
<p>The resin infusion was treated with acetic anhydride and a few drops of concentrated sulfuric acid were added and heated gently. Formation of a greenish or bluish coloration confirmed hydroxyl groups in triterpenoid acids [<xref ref-type="bibr" rid="B24">24</xref>].</p>
</sec>
<sec id="s2-3-4">
<title>Foam test (for saponins)</title>
<p>The resin infusion was dissolved in water and shaken vigorously. Persistent foam formation indicated the presence of saponins, which are sometimes present as minor constituents [<xref ref-type="bibr" rid="B25">25</xref>].</p>
</sec>
<sec id="s2-3-5">
<title>Fehling&#x2019;s test (for reducing sugars, if present as impurities)</title>
<p>The resin infusion was dissolved in water and equal volumes of Fehling&#x2019;s A and B solutions were added and heated gently. Formation of a red or orange precipitate indicated presence of reducing sugars [<xref ref-type="bibr" rid="B22">22</xref>].</p>
</sec>
<sec id="s2-3-6">
<title>Ferric chloride test (for phenolic compounds)</title>
<p>1-2 drops of 5% ferric chloride solution were added to both the resin solutions. A deep blue, green, or purple color indicated the presence of flavonoids [<xref ref-type="bibr" rid="B22">22</xref>].</p>
</sec>
<sec id="s2-3-7">
<title>Alkaloid tests</title>
<sec id="s2-3-7-1">
<title>Dragendorff&#x2019;s test</title>
<p>To the powdered drug or infusion, upon adding the Dragendorff&#x2019;s reagent (Potassium iodide &#x2b; Bismuth nitrate), appearance of orange red color precipitate indicated presence of alkaloids [<xref ref-type="bibr" rid="B22">22</xref>].</p>
</sec>
<sec id="s2-3-7-2">
<title>Mayer&#x2019;s reagent test</title>
<p>To the powdered drug or infusion, upon adding the Mayer&#x2019;s reagent (Potassium mercuric iodide) formation of cream color precipitate showed the presence of alkaloids [<xref ref-type="bibr" rid="B26">26</xref>].</p>
</sec>
<sec id="s2-3-7-3">
<title>Hager&#x2019;s reagent test</title>
<p>To the powdered drug or infusion, upon adding the Hager&#x2019;s reagent (saturated solution of picric acid), development of an orange yellow precipitate indicated presence of alkaloids [<xref ref-type="bibr" rid="B27">27</xref>].</p>
</sec>
<sec id="s2-3-7-4">
<title>Wagner&#x2019;s reagent test</title>
<p>To the powdered drug or infusion, upon adding the Wagner&#x2019;s (Iodine solution) reagent, formation of a brown flocculent precipitate indicated presence of alkaloids [<xref ref-type="bibr" rid="B28">28</xref>].</p>
</sec>
</sec>
</sec>
<sec id="s2-4">
<title>Antioxidant activity</title>
<p>The antioxidant activities of frankincense infusions were determined using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. The samples were coded as Sample 1 (plain almond oil), Sample 2 (oil infusion of frankincense resin), Sample 3 (plain rosewater), and Sample 4 (rosewater infused frankincense resin). A 0.024&#xa0;mg/mL solution of DPPH was prepared by dissolving 2.4&#xa0;mg of DPPH in 100&#xa0;mL methanol. Serial dilutions of each test sample (Sample 1 &#x2013; Sample 4) and the standard antioxidant gallic acid were prepared in methanol to obtain different concentrations. For each assay, 5&#xa0;&#xb5;L of the respective sample or standard was added to 3.995&#xa0;mL of the DPPH solution in a test tube. The reaction mixtures were mixed vigorously and incubated in the dark at room temperature for 30&#xa0;min to allow complete reaction between the antioxidant compounds and the DPPH radicals. A control solution containing DPPH and methanol without sample or standard served as a blank to determine baseline absorbance. After incubation, the absorbance of each mixture was measured at 517&#xa0;nm against blank using a UV-Vis spectrophotometer. All measurements were performed in triplicate to ensure accuracy and reproducibility and the results are expressed as mean &#xb1; standard deviation (SD) [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Antioxidant activity was expressed as a percentage inhibition of DPPH radicals and calculated using the following equation:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>s</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>e</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Where <italic>A</italic>
<sub>
<italic>control</italic>
</sub> is the absorbance of the DPPH solution without sample, and <italic>A</italic>
<sub>
<italic>sample</italic>
</sub> is the absorbance with the test sample.</p>
</sec>
<sec id="s2-5">
<title>Formulation of <italic>w/o</italic> frankincense cream</title>
<p>A w/o emulsion-based cream was formulated by incorporating both oil and water infusions of frankincense. The formulation process included several stages starting from preparation of oil phase by combining oil infusion (30&#xa0;g) with beeswax (7.5&#xa0;g) and heating to 75&#xa0;&#xb0;C until the beeswax is melted completely. This was followed by preparation of aqueous phase where the water infusion (14&#x2013;23&#xa0;g, depending upon the formulation batch) was heated separately to the same temperature (<xref ref-type="table" rid="T1">Table 1</xref>). Eventually, the aqueous phase was added slowly into the oily phase with continuous stirring until both the phases were mixed properly. The cream formulation was removed from heat and kept stirring at room temperature until it was cooled and thickened, yielding a smooth and homogeneous <italic>w/o</italic> cream. A plain cream was also formulated following the same procedure using plain almond oil and rosewater, but without frankincense extracts.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Ingredients and their proportions used in formulation development.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Ingredients</th>
<th align="left">Weight by part</th>
<th align="left">Weight in grams</th>
<th align="left">Uses</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Beeswax</td>
<td align="center">1 part</td>
<td align="center">7.5&#xa0;g</td>
<td align="left">Emulsifier</td>
</tr>
<tr>
<td align="left">Sweet almond oil infusion</td>
<td align="center">4 parts</td>
<td align="center">30&#xa0;g</td>
<td align="left">Oily phase</td>
</tr>
<tr>
<td align="left">Rosewater infusion</td>
<td align="center">2/3 parts</td>
<td align="center">14/23&#xa0;g</td>
<td align="left">Water phase</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-6">
<title>Evaluation of cream formulations</title>
<p>The prepared cream formulations were subjected to a series of physicochemical evaluations [<xref ref-type="bibr" rid="B31">31</xref>].</p>
<sec id="s2-6-1">
<title>Organoleptic properties</title>
<p>Physical properties such as appearance, color, odor, and texture of developed cream formulations were recorded visually.</p>
</sec>
<sec id="s2-6-2">
<title>Determination of pH</title>
<p>The pH was measured by dispersing 0.5&#xa0;g of the cream formulation in 50&#xa0;mL of distilled water and recording the value with a calibrated digital pH meter.</p>
</sec>
<sec id="s2-6-3">
<title>Viscosity</title>
<p>Viscosity of the developed cream formulation was determined using Brookfield viscometer (SHIMADZU, Japan) at 25 &#xb1; 0.5&#xa0;&#xb0;C following standard procedures reported for topical formulations [<xref ref-type="bibr" rid="B32">32</xref>], and the results were expressed in centipoise (cP). The rheological behaviour of the formulation was evaluated by recording viscosity at different spindle speeds.</p>
</sec>
<sec id="s2-6-4">
<title>Spreadability</title>
<p>Spreadability of the formulation was evaluated by the slip-and-drag method, measuring the time required for two glass slides with cream between them to slip under specified weight [<xref ref-type="bibr" rid="B33">33</xref>].</p>
</sec>
<sec id="s2-6-5">
<title>Phase separation</title>
<p>Cream formulations were stored at varying temperatures of 4&#xa0;&#xb0;C, 25&#xa0;&#xb0;C, and 40&#xa0;&#xb0;C and were inspected at set intervals (24 h, 7 days, 14 days, 28 days) for any signs of clear layers, oiling-out, or water pooling. Three freeze-thaw cycles were run and re-inspected.</p>
</sec>
<sec id="s2-6-6">
<title>Consistency</title>
<p>The consistency of the developed cream formulations was assessed by spreading the formulations on skin and observing its ease of application and feel.</p>
</sec>
<sec id="s2-6-7">
<title>Liquefaction</title>
<p>Cream samples were placed in marked vials at graded temperatures (40 &#x2013; 60&#xa0;&#xb0;C) and inverted at defined times (0.5, 1, 2, 4, 24&#xa0;h) and any continuous flow was observed. Time-to-flow and signs of oil pooling, if any, was recorded and the lowest temperature at which continuous flow begins, was noted.</p>
</sec>
<sec id="s2-6-8">
<title>Thermal behaviour</title>
<p>Heating-cooling stability of formulations was assessed at 4&#xa0;&#xb0;C for 24&#xa0;h then 40&#xa0;&#xb0;C for 24&#xa0;h per cycle for 3 consecutive cycles. Any visible changes or phase separation was observed after each cycle.</p>
</sec>
<sec id="s2-6-9">
<title>Grittiness</title>
<p>Grittiness of the formulation was assessed by gently rubbing the cream between fingers and observing under a microscope for the presence of coarse particles.</p>
</sec>
<sec id="s2-6-10">
<title>Washability</title>
<p>Washability was assessed by applying the cream formulation to skin and washing off with tap water, observing ease of removal.</p>
</sec>
<sec id="s2-6-11">
<title>Rheological behaviour</title>
<p>The rheological behaviour of cream formulation was measured with the help of Brookfield viscometer. 50&#xa0;g of cream formulation was transferred to a 100&#xa0;mL beaker and equilibrated at 25 &#xb1; 0.5&#xa0;&#xb0;C for 30&#xa0;min. Suitable spindle was selected and immersed so that the cream covered the spindle mark. Viscosity values were recorded at different spindle speeds (5 &#x2013; 100&#xa0;rpm) to observe change in viscosity with shear rate [<xref ref-type="bibr" rid="B34">34</xref>].</p>
</sec>
<sec id="s2-6-12">
<title>Stability studies</title>
<p>The stability studies were carried out by storing the creams at different temperatures (4&#xa0;&#xb0;C, room temperature, and 40&#xa0;&#xb0;C) and under freeze-thaw cycles. Visual observations were made for phase separation, liquefaction, or other signs of instability.</p>
</sec>
<sec id="s2-6-13">
<title>FT-IR spectroscopy</title>
<p>The chemical characteristics of frankincense resin sample (S1), oil infusion (S2), water infusion (S3), plain cream formulation without frankincense (S4), and the cream formulation with combined frankincense infusions (S5) were evaluated using FT-IR spectroscopy to evaluate any possible interactions between the infusions and excipients. The FT-IR spectra were recorded over a transmittance range of 4,000 &#x2013; 400&#xa0;cm<sup>&#x2212;1</sup> and at a resolution of 4&#xa0;cm<sup>&#x2212;1</sup> using silicone discs and major absorption peaks were assigned based on known characteristic frequencies.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Phytochemical profiling</title>
<p>The qualitative phytochemical profiling of frankincense oil and water infusions was performed using standard qualitative tests for the detection of terpenoids, steroids, saponins, alkaloids, and phenolic compounds and the results revealed distinct differences in the types of secondary metabolites extracted into each medium (<xref ref-type="table" rid="T2">Table 2</xref>). The oil infusion exhibited strong positive reactions for triterpenoids and steroids as observed in the Salkowski test and Liebermann-Burchard test, which was consistent with the lipophilic nature of these compounds. The hydroxyl functional groups were also predominantly detected in the oil infusion by the acetylation test, reflecting the presence of alcohol-containing triterpenoids and boswellic acid derivatives. On the contrary, the water infusion showed a positive foam test indicating presence of saponins, as well as trace amounts of alkaloids as detected by the Dragendorff&#x2019;s and Mayer&#x2019;s reagent tests. Reducing sugars were also weakly detected, while phenolic compounds gave faint responses with the ferric chloride reagent. These findings suggested that the oil infusion consisted primarily of the lipophilic terpenic and resinous components, while the water infusion showed presence of hydrophilic polysaccharides, saponins, and small amounts of alkaloids.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Results of phytochemical analysis of oil and water infusions of frankincense resin.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">S. No</th>
<th align="left">Phytochemicals</th>
<th align="left">Test</th>
<th align="left">Blank 1 (rosewater only)</th>
<th align="left">Water infusion of resin</th>
<th align="left">Blank 2 (almond oil only)</th>
<th align="left">Oil infusion of resin</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">Triterpenoids and steroids</td>
<td align="left">Salkowski test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">Triterpenoids</td>
<td align="left">Liebermann-Burchard test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">Hydroxyl groups in boswellic acids</td>
<td align="left">Acetylation test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2b;</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">Saponins</td>
<td align="left">Foam test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2b;</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">Reducing sugars</td>
<td align="left">Fehling&#x2019;s test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
<tr>
<td rowspan="2" align="left">6</td>
<td rowspan="2" align="left">Carbohydrates</td>
<td align="left">Molisch test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
</tr>
<tr>
<td align="left">Resorcinol test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">Phenolic compounds</td>
<td align="left">Ferric chloride test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
<tr>
<td rowspan="4" align="left">8</td>
<td rowspan="4" align="left">Alkaloids</td>
<td align="left">Dragendorff&#x2019;s test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
<tr>
<td align="left">Mayer&#x2019;s test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
<tr>
<td align="left">Hager&#x2019;s test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
<tr>
<td align="left">Wagner&#x2019;s test</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2212;</td>
<td align="center">&#x2212;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Antioxidant activity</title>
<p>The DPPH assay is a widely used method to evaluate the free radical scavenging ability of compounds. The antioxidant potential of four treatment groups was evaluated based on their concentration (&#xb5;g/mL) using the DPPH radical scavenging assay and the results are shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. The percentage inhibition of DPPH radicals and the corresponding antioxidant concentrations (expressed in &#xb5;g/mL) for four different samples, labeled as sample 1 (plain almond oil), sample 2 (oil infusion of frankincense resin), sample 3 (plain rosewater), and sample 4 (rosewater infusion of frankincense resin) are presented in <xref ref-type="table" rid="T3">Table 3</xref>. Among the samples, sample 2 exhibited highest antioxidant activity with a 71% inhibition and a corresponding concentration of 343.46 &#xb1; 34.2&#xa0;&#x3bc;g/mL, indicating strong free radical scavenging ability of the sample. Sample 4 and sample 3 also showed good antioxidant activities with inhibition rates of 57% and 53%, and concentrations of 275.74 &#xb1; 46.4&#xa0;&#x3bc;g/mL and 256.39 &#xb1; 38.9&#xa0;&#x3bc;g/mL, respectively. Sample 1 showed the lowest antioxidant activity, with a 40% inhibition and a concentration of 193.50 &#xb1; 28.1&#xa0;&#x3bc;g/mL. As evident from the results, a positive correlation between % inhibition and the antioxidant concentration were observed, suggesting that higher concentrations were associated with greater free radical scavenging activity. Results showed varying degrees of antioxidant potential among the samples, with sample 2 demonstrating the most potent activity. Overall antioxidant activity of tested samples followed the order: sample 2 &#x3e; sample 4 &#x3e; sample 3 &#x3e; sample 1. These differences highlighted the potential influence of different phytochemical compositions of the samples. Strikingly high activity in sample 2 makes it a promising candidate for applications related to oxidative stress or as a natural antioxidant source in pharmaceutical or nutraceutical formulations.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>DPPH radical scavenging activity of different samples 1-4 and standard gallic acid (positive control). Values are expressed as mean &#xb1; SD (n &#x3d; 3). Sample 1: plain almond oil; sample 2: almond oil infusion of frankincense resin; sample 3: plain rosewater; and sample 4: rosewater infusion of frankincense resin.</p>
</caption>
<graphic xlink:href="jpps-29-15609-g002.tif">
<alt-text content-type="machine-generated">Bar chart titled DPPH Radical Scavenging Activity comparing concentrations in micrograms per milliliter for five samples: almond oil (198.5), frankincense oil infusion (343.46), rosewater (275.74), frankincense water infusion (256.39), and standard gallic acid (483.75), with error bars shown for each sample.</alt-text>
</graphic>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Percentage inhibition and corresponding antioxidant concentrations of tested samples as determined by the DPPH assay.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Samples<xref ref-type="table-fn" rid="Tfn1">&#x2a;</xref>
</th>
<th align="center">% inhibition</th>
<th align="center">Concentration (&#xb5;g/mL)<break/>Mean &#xb1; SD</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Sample 1</td>
<td align="center">40</td>
<td align="center">193.50 &#xb1; 28.1</td>
</tr>
<tr>
<td align="center">Sample 2</td>
<td align="center">71</td>
<td align="center">343.46 &#xb1; 34.2</td>
</tr>
<tr>
<td align="center">Sample 3</td>
<td align="center">53</td>
<td align="center">256.39 &#xb1; 38.9</td>
</tr>
<tr>
<td align="center">Sample 4</td>
<td align="center">57</td>
<td align="center">275.74 &#xb1; 46.4</td>
</tr>
<tr>
<td align="center">Standard (gallic acid)</td>
<td align="center">97</td>
<td align="center">483.75 &#xb1; 27.4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>&#x2a;</label>
<p>Sample 1: plain almond oil; sample 2: almond oil infusion of frankincense resin; sample 3: plain rosewater; and sample 4: rosewater infusion of frankincense resin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-3">
<title>Evaluation of cream formulation</title>
<p>The plain and combined infusion cream formulations were analyzed on the basis of various evaluation parameters to ensure the development of formulation with desired properties. The observations are summarized in <xref ref-type="table" rid="T4">Table 4</xref>.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Physicochemical evaluation of plain and combined infusion cream formulations.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Parameters</th>
<th align="left">Plain formulation</th>
<th align="left">Combined infusion formulation</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Color</td>
<td align="left">White</td>
<td align="left">Fawn</td>
</tr>
<tr>
<td align="left">Feel</td>
<td align="left">Smooth</td>
<td align="left">Smooth</td>
</tr>
<tr>
<td align="left">Odour</td>
<td align="left">Odourless</td>
<td align="left">Pleasant</td>
</tr>
<tr>
<td align="left">Homogeneity</td>
<td align="left">Satisfying</td>
<td align="left">Homogenous</td>
</tr>
<tr>
<td align="left">pH</td>
<td align="left">7.55</td>
<td align="left">7.28</td>
</tr>
<tr>
<td align="left">Viscosity (cP)</td>
<td align="left">1350</td>
<td align="left">1200</td>
</tr>
<tr>
<td align="left">Phase separation</td>
<td align="left">Little phase separation</td>
<td align="left">No phase separation</td>
</tr>
<tr>
<td align="left">Consistency</td>
<td align="left">Good</td>
<td align="left">Softer</td>
</tr>
<tr>
<td align="left">Liquefaction</td>
<td align="left">Immediate</td>
<td align="left">Delayed</td>
</tr>
<tr>
<td align="left">Thermal behaviour</td>
<td align="left">Found in stable state at room temperature (25&#xa0;&#xb0;C), refrigerator (4&#xa0;&#xb0;C) and at 40&#xa0;&#xb0;C for 3 consecutive cycles</td>
<td align="left">Found in stable state at room temperature (25&#xa0;&#xb0;C), refrigerator (4&#xa0;&#xb0;C) and at 40&#xa0;&#xb0;C for 3 consecutive cycles</td>
</tr>
<tr>
<td align="left">Grittiness</td>
<td align="left">None</td>
<td align="left">None</td>
</tr>
<tr>
<td align="left">Spreadability</td>
<td align="left">8&#x2013;10&#xa0;s</td>
<td align="left">7&#xa0;s</td>
</tr>
<tr>
<td align="left">Washability</td>
<td align="left">Difficult to wash</td>
<td align="left">Easily washable</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3-3-1">
<title>Organoleptic properties</title>
<p>The plain formulation exhibited a stark white color, while the infusion-based formulation showed a more appealing fawn color. This color variation is attributed to the presence of natural pigments in the infusions, which could impart a subtle color to the final product. Both the formulations showed smooth texture, indicating desirable tactile experience for the end-user. A smooth texture is crucial for cosmetic products, as it ensures easy application and minimizes discomfort during use. A significant difference was observed in the odor profile of both the products as the plain formulation was odourless, while the infusion-based formulation had a pleasant aroma owing to the presence of volatile oils and terpenoids in the infusion. Both formulations demonstrated satisfactory level of homogeneity, suggesting uniform distribution of ingredients throughout the product. A homogeneous product ensured consistent performance and prevented the separation of components, which is crucial for maintaining product stability and efficacy.</p>
</sec>
<sec id="s3-3-2">
<title>Determination of pH</title>
<p>The plain cream formulation exhibited a pH of 7.55, while the infusion-based formulation displayed a slightly lower pH of 7.28, which falls within the acceptable range for topical formulations, though slightly higher than the natural skin surface pH.</p>
</sec>
<sec id="s3-3-3">
<title>Viscosity</title>
<p>The viscosity of frankincense cream was observed to be lesser than the plain cream formulation, and was calculated to be approximately 1,200&#xa0;cP, which indicated adequate thickness and stability suitable for topical applications. The rheological behaviour observed was shear-thinning, which is typical for non-Newtonian fluids and crucial for the ease of application. It is desirable for cream formulations as it allows easy spreading under mechanical stress while maintaining stability at rest.</p>
</sec>
<sec id="s3-3-4">
<title>Spreadability</title>
<p>Spreadability was tested by spreading the formulations between glass slides under applied weight and it was observed that the creams had variable spreading patterns. Plain formulation (8&#x2013;10&#xa0;s) took longer to spread than the infusion-based formulation (7&#xa0;s).</p>
</sec>
<sec id="s3-3-5">
<title>Phase separation</title>
<p>In contrast to the plain cream formulation where a little phase separation was observed, the combined infusion-based formulation demonstrated no visible phase separation during the stability tests, suggesting good compatibility of the oil and water phases with the emulsifiers used (<xref ref-type="fig" rid="F3">Figure 3</xref>). Incorporating natural resins and plant extracts stabilized the cream matrix, which might be due to the interaction between emulsifiers and active components [<xref ref-type="bibr" rid="B35">35</xref>].</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Photographic representation of stability evaluation of the frankincense cream, formulation under different storage conditions including <bold>(A)</bold> Day 0&#xa0;at room temperature; <bold>(B)</bold> under refrigerated conditions (4&#xa0;&#xb0;C); <bold>(C)</bold> plain cream formulation at day 0&#xa0;at room temperature; and <bold>(D)</bold> frankincense cream formulation at accelerated temperature 40&#xa0;&#xb0;C.</p>
</caption>
<graphic xlink:href="jpps-29-15609-g003.tif">
<alt-text content-type="machine-generated">Four labeled panels show beakers containing thick, creamy, or paste-like substances in pale yellow and off-white colors, each with a glass stirring rod. Panels A and C depict the substance clinging to the rod, while panels B and D show variations in texture and consistency.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3-6">
<title>Consistency</title>
<p>The addition of frankincense infusion resulted in a slightly softer consistency compared to the plain formulation, which might be due to the resin&#x2019;s unique composition of polysaccharides and volatile oils. This was also influenced by the lipid content, emulsifiers, and the effect of infusions on the cream matrix.</p>
</sec>
<sec id="s3-3-7">
<title>Liquefaction</title>
<p>The extract formulation showed delayed liquefaction compared to the plain formulation, indicating improved thermal stability. Studies involving other herbal-based creams, such as those formulated with <italic>Lavandula angustifolia</italic> and <italic>Aloe vera</italic> also reported enhanced stability due to the presence of bioactive compounds that reinforce the structural matrix [<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>].</p>
</sec>
<sec id="s3-3-8">
<title>Thermal behaviour</title>
<p>The incorporation of frankincense infusion to the cream formulation improved the its thermal behaviour, as evidenced by its stability over a wide range of temperatures. The interaction between the resin&#x2019;s boswellic acids and the cream&#x2019;s lipid phase might have contributed to the enhanced thermal resilience (<xref ref-type="fig" rid="F3">Figure 3D</xref>). It was consistent with the findings reported for the formulations containing natural resins and gums, where the complex molecular structures provided thermal resistance [<xref ref-type="bibr" rid="B38">38</xref>].</p>
</sec>
<sec id="s3-3-9">
<title>Grittiness</title>
<p>No gritty particles were found in both the formulations while observing under the microscope and when pressed between fingers.</p>
</sec>
<sec id="s3-3-10">
<title>Washability</title>
<p>The frankincense infusion-based cream could easily be removed upon washing, while the plain formulation was comparatively difficult to wash.</p>
</sec>
<sec id="s3-3-11">
<title>Rheological behaviour</title>
<p>Creams are characterized by their semi-solid nature and respond differently when subjected to stress (force). The cream sample under examination was identified as shear-thinning, as a decrease in viscosity was observed with an increase in stress. This behaviour was a prevalent form of time-independent non-Newtonian fluid dynamics, which is closely associated with the spreadability of cosmetics when applied to human skin [<xref ref-type="bibr" rid="B39">39</xref>] (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Rheological behaviour of frankincense cream formulation showing effect of spindle speed on viscosity using Brookfield viscometer at 25&#xa0;&#xb0;C. The decrease in viscosity with increasing spindle speed indicated pseudoplastic (shear-thinning) behaviour of the formulation.</p>
</caption>
<graphic xlink:href="jpps-29-15609-g004.tif">
<alt-text content-type="machine-generated">Line graph illustrating the rheological study of a cream formulation shows viscosity in centipoise decreasing as spindle speed in revolutions per minute increases. An inset table provides exact measurements at each speed level.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3-12">
<title>FT-IR spectroscopic analysis</title>
<p>The overlay and stacked FT-IR spectra of samples in the order S1, S2, S3, S4, S5 at mid infrared (IR) region (4,000-500 cm<sup>&#x2212;1</sup>) are shown in <xref ref-type="fig" rid="F5">Figures 5A,B</xref>. In this study, the selection of samples relied on its availability in the cream formulation. The spectra of S4 (plain cream formulation without resin) and S5 (final cream formulation with resin) appeared to be similar indicating no interaction between the natural components and appearance of typical characteristic of absorption bands. Each peak in FT-IR spectra corresponded to functional groups responsible for IR absorption. In S1 (pure frankincense resin), FT-IR spectrum exhibited an absorption peak at 3,382&#xa0;cm<sup>-1</sup> caused by asymmetric stretching vibrations of -OH functional group. Several other bands were also observed at 2,971, 1711, 1,452, 1,378, 1,264, 1,048 and 880&#xa0;cm<sup>&#x2212;1</sup> which can be attributed to stretching vibrations -C-H, -C&#x3d;O stretching vibrations, N-H bending vibrations in a plane, C-H bending vibrations, C-O stretching vibrations, C-C bending vibrations, and N-H out-of-plane bending vibrations respectively. These results were concordant with the FT-IR analysis of frankincense resin present in the literature [<xref ref-type="bibr" rid="B40">40</xref>]. In S2 (almond oil infusion of frankincense resin), absorption peaks were observed at 3,471, 2,925, 1744, 1,462, 1,376, 1,240, 1,026 and 724&#xa0;cm<sup>&#x2212;1</sup>. This clearly indicated that the oil soluble components from resin were successfully infused in plain almond oil. In S3 (Madinah rosewater infusion of frankincense resin), modified absorption peaks were observed at 3,390, 2,925, 1867, 1741, 1,645, 1,514, 1,454, 1,427, 1,070&#xa0;cm<sup>&#x2212;1</sup>. These could be due to the presence of water-soluble resin components in rosewater.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> Overlay; and <bold>(B)</bold> stacked FT-IR spectra of pure frankincense resin (S1), oil infusion (S2), water infusion (S3), plain cream formulation (S4) and combined infusion formulation (S5). The preservation of characteristic absorption peaks indicated successful incorporation of frankincense constituents into the cream matrix without chemical interaction.</p>
</caption>
<graphic xlink:href="jpps-29-15609-g005.tif">
<alt-text content-type="machine-generated">Panel A displays an overlaid Fourier-transform infrared (FTIR) spectroscopy graph with five distinct spectra in different colors, each labeled S1 to S5, showing transmittance versus wavenumber. Panel B contains five individual FTIR spectra labeled S1 through S5, each showing characteristic peaks and wavenumber values on the x-axes and intensity on the y-axes, with key absorption peaks annotated for each sample.</alt-text>
</graphic>
</fig>
<p>Sample S4 (plain cream formulation without frankincense resin) showed no absorption band characteristic to frankincense resin indicating its absence from the formulation. Lastly, in S5 (frankincense cream formulation containing combined infusions of resin), absorption bands were found intact at 3,451, 2,921, 1744, 1,462, 1,375, 1,238, 1,029, and 723&#xa0;cm<sup>&#x2212;1</sup> indicating the presence of all functional groups corresponding to the frankincense resin. It also showed peaks at 1,653, 1,514&#xa0;cm<sup>-1</sup> similar to the S3 sample. The purpose of this study was to ensure that the final frankincense resin-based cream formulation possessed all the oil and water-soluble resinous components of frankincense for maximum skincare activity and no interaction was observed between the frankincense constituents and the cream base. The cream matrix maintained the structural integrity of the active phytochemicals. These findings support the successful incorporation of both hydrophilic and lipophilic components of frankincense into the <italic>w/o</italic> cream formulation without compromising their functional groups.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The present study focuses on identification, qualitative chemical profiling and a conventional cream formulation development of combined infusions of frankincense resin. It sought to combine the traditional knowledge of frankincense use with modern phytochemical and formulation approaches, resulting in the successful development of <italic>w/o</italic> nourishing and anti-aging cream containing both oil- and water-soluble fractions of the resin. The two infusions showed distinct phytochemical compositions, contributing to antioxidant activity and stability of the developed formulation, thereby providing a strong scientific rationale for its potential application as a dermocosmetic agent. An all-natural skincare formulation was developed which consisted of pure frankincense resin infusion, pure almond oil, beeswax and Madinah rosewater as main ingredients. Frankincense essential oil has been reported to have anti-inflammatory, antibacterial and antioxidant properties that benefit all skin types, including acne and blemish-prone skin, wrinkles, and dry skin [<xref ref-type="bibr" rid="B15">15</xref>].</p>
<p>Essential oils and plant-derived extracts have garnered increasing attention in pharmaceutical and cosmeceutical research owing to their diverse biological effects including antioxidant, antimicrobial, and anti-inflammatory. These natural products have long been widely investigated for their potential applications in formulations intended for dermatological and skin-care products [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. Frankincense essential oil is known to stimulate new cell production, preserves skin elasticity, and relieves dry and chapped skin [<xref ref-type="bibr" rid="B43">43</xref>]. It is an effective antiwrinkle and antiaging agent that may also be used to treat psoriasis and dermatitis [<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>]. Beeswax is a hydrophobic compound, which is structurally a complex mixture of alkanes, alkenes, free fatty acids, monoesters, diesters, and hydroxy-monoesters, and is useful in skin care products as natural a natural emulsifier [<xref ref-type="bibr" rid="B46">46</xref>]. It is generally an essential part of any cream formulation as it thickens the cream and keeps the oil and water phases of the cream from separating. It also acts as an occlusive, which helps to create a semi-occlusive skin barrier that minimizes trans-epidermal water loss; an emollient, which softens and soothes the skin; and a humectant, which locks in hydration in the skin [<xref ref-type="bibr" rid="B47">47</xref>]. High amounts of propolis in beeswax contribute to its antimicrobial [<xref ref-type="bibr" rid="B48">48</xref>], antioxidant [<xref ref-type="bibr" rid="B49">49</xref>], and anti-inflammatory properties [<xref ref-type="bibr" rid="B50">50</xref>]. Almond oil is widely used to soothe and moisturize the skin. It is also rich in vitamin E, which helps protect the skin from harmful UV radiation. Therapeutic properties of almond oil include anti-inflammatory, immune-stimulating, and anti-hepatotoxic activities [<xref ref-type="bibr" rid="B51">51</xref>]. Madinah rosewater was used instead of plain water as it has a cooling impact on the skin, has good aroma, and rose extracts themselves are considered as a good source of antioxidants. Additionally, it has antibacterial effects on a variety of microflora, anti-inflammatory, moisturizing, and soothing properties [<xref ref-type="bibr" rid="B52">52</xref>].</p>
<p>Qualitative chemical analysis confirmed that the oil infusion was rich in triterpenoids and related boswellic acid-type constituents, whereas the water infusion consisted primarily of saponins, polysachharides, and trace amount of alkaloids. The detection of hydroxyl and carbonyl functional groups in FT-IR spectra further supported the presence of boswellic acids and associated terpenoids in the oil extract. Incorporating both the fractions in a single formulation may allow for broader therapeutic coverage as the anti-inflammatory and antioxidante effects of triterpenoids are combined with the moisturizing and emulsifying properties of polysaccharides and saponins. Phytochemicals from <italic>B. serrata</italic> and <italic>B. carterii</italic> were identified previously, where the ratio of AK&#x3b2;-BA (acetyl-11-keto-&#x3b2;- boswellic acid) to K&#x3b2;-BA (11-keto-&#x3b2;-boswellic acid) differed significantly [<xref ref-type="bibr" rid="B53">53</xref>]. In another similar study, it was revealed that the resinous portion of <italic>B. serrata</italic> contained monoterpenes, diterpenes, triterpenes, tetracyclic triterpenic acids, and four main pentacyclic triterpenic acids, which were responsible for inhibiting pro-inflammatory enzymes [<xref ref-type="bibr" rid="B54">54</xref>]. Acetyl-11-keto-&#x3b2;-boswellic acid was the most effective of these boswellic acids at inhibiting the inflammation-causing enzyme 5-lipoxygenase.</p>
<p>The DPPH radical scavenging assay demonstrated that the almond oil infusion of frankincense resin possessed the highest antioxidant activity, followed by the rosewater infusion, plain rosewater, and plain almond oil. The stronger antioxidant action of the oil infusion could be attributed to the abundance of lipophilic boswellic acids and terpenoids in the infusion, many of which have been reported to neutralize free radicals and modulate oxidative pathways. While the rosewater infusion exhibited comparatively weaker antioxidant activity, its inclusion in the formulation will further contribute to its overall antioxidant potential. Any skincare formulation containing bioactives of high antioxidant potential help neutralise the free radicals, thereby preventing the damage caused by reactive oxygen and reactive nitrogen species. The antioxidant potential of frankincense resin is well documented in the literature [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>].</p>
<p>Anti-photoaging effect of frankincense (<italic>B</italic>. <italic>papyrifera</italic> (Del.) Hochst., family Burceraceae) was studied recently in an <italic>in vivo</italic> model. Superior anti-aging effect of frankincense oil were observed compared to epigallocatechin gallate. The frankincense oil was subsequently formulated in solid lipid nanoparticles through high shear homogenization process to improve solubility and skin penetration characteristics [<xref ref-type="bibr" rid="B15">15</xref>]. In another study, antioxidant activity of frankincense oil was evaluated with DPPH and ABTS methods with the resulting inhibition of 73.88 &#xb1; 0.35% of DPPH radical and 97.09 &#xb1; 0.48% of ABTS radical cation was reported [<xref ref-type="bibr" rid="B57">57</xref>]. In another study reported earlier, antioxidant properties of various solvent extracts (methanol, ethanol, acetone, water) of Indian frankincense (<italic>B. serrata</italic>) oleogum resin were carried out by DPPH radical scavenging activity, reducing power assay, total antioxidant capacity, and oxidative stability index (Rancimat test). Various solvent extracts of <italic>B. serrata</italic> showed varying degrees of antioxidant activity in different test systems in a concentration dependent manner. Methanol was found to be the most efficient solvent for extraction of antioxidants from <italic>B. serrata</italic> and exhibited strongest antioxidant potential in all assays used [<xref ref-type="bibr" rid="B58">58</xref>].</p>
<p>Apart from having a high antioxidant potential, frankincense resin also has anti-inflammatory, antifungal and antibacterial properties, offering new possibilities for its use as an active skincare agent. TNF&#x3b1;, IL-1&#x3b2;, and IL-6 are examples of pro-inflammatory cytokines that are crucial to the inflammatory response and the regulation of both acute and chronic inflammation is significantly influenced by these inflammatory cytokines [<xref ref-type="bibr" rid="B59">59</xref>]. Monoterpenes, diterpenes, triterpenes, tetracyclic triterpenic acids, and four primary pentacyclic triterpenic acids&#x2014;l-boswellic acid, acetyl-l-boswellic acid, 11-keto-l-boswellic acid, and acetyl-11-keto-l-boswellic acid&#x2014;are all present in the resinous portion of <italic>B. serrata</italic>, which are known to downregulate these pro-inflammatory cytokines [<xref ref-type="bibr" rid="B54">54</xref>].</p>
<p>The <italic>w/o</italic> cream formulation prepared using combined oil- and water-infusions of frankincense resin demonstrated favourable physicochemical properties suitable for topical use, including smooth texture, uniformity, viscosity and an acceptable pH of 7.28. Notably, stability studies revealed no evidence of phase separation, liquefaction, or grittiness under different thermal conditions and freeze-thaw cycles, indicating the robustness of the emulsion system. Rheological assessment indicated shear-thinning behaviour, which is a desirable attribute of a cream formulation ensuring ease of spread upon application while maintaining stability at storage. The FT-IR analysis of infusions and formulations provided important data about the integrity of chemical composition as major functional groups of frankincense resin were retained in the final cream formulation. The active constituents remained intact within the cream base and no significant interactions with excipients were noticed. Comprehensive biological evaluation of plant-derived bioactive components often requires a combination of <italic>in vitro</italic>, <italic>ex vivo</italic>, and <italic>in vivo</italic> studies to fully establish their therapeutic potential [<xref ref-type="bibr" rid="B60">60</xref>].</p>
<sec id="s4-1">
<title>Limitations of the study and future directions</title>
<p>Despite promising results, this study has several limitations as it represents a preliminary formulation development and <italic>in vitro</italic> evaluation study. The phytochemical characterization of the infusions was limited to qualitative screening; therefore, future investigations are warranted to quantify specific boswellic acids, terpenes, and polysaccharides using advanced chromatographic methods such as HPLC, LC-MS, or GC-MS, which would further help correlate phytochemical constituents with the observed antioxidant activity. Similarly, the antioxidant potential was assessed only by the DPPH assay, which, although widely employed, represents a chemical model rather than having biological relevance. Complementary assays and <italic>in vitro</italic> cell-based antioxidant or anti-inflammatory models could be performed. Future studies should also include cytotoxicity assays using keratinocyte or fibroblast cell lines together with the skin compatibility studies to further examine the dermatological applicability of the developed formulation. Molecular docking analysis, cell-based assays, and mechanistic investigations can also be performed to better understand the interaction of boswellic acids and related phytoconstituents with molecular targets involved in the oxidative stress and skin aging pathways. Statistical optimization approaches such as factorial design and response surface methodology can be applied for the development and optimization of formulation to improve drug delivery performance. Additionally, a pH of 7.28 is although in a tolerable range of pH of topical formulation, it is slightly higher than the skin surface pH (&#x223c;5.5) and this could have effect on long-term tolerability. Further formulation adjustments are needed to bring the cream closer to the skin pH. Lastly, formal <italic>in vivo</italic> and <italic>ex vivo</italic> evaluation such as skin permeation studies, and irritancy/sensitization testing are essential to substantiate the claims of anti-aging and dermocosmetic efficacy. Future investigation may also explore advanced delivery systems and permeation-enhancing formulations to further improve dermal bioavailability of frankincense constituents. Considering the reported antimicrobial properties of frankincense resin, future investigations may also focus on assessing antibacterial activity of the developed formulation against common skin pathogens. These additional investigations are needed to be performed to establish the pharmacological relevance, safety profile, and dermal bioavailability of the bioactive components of frankincense prior to clinical applications.</p>
</sec>
<sec id="s4-2">
<title>Conclusion</title>
<p>In conclusion, the present study demonstrated extraction, characterization, and development of a stable <italic>w/o</italic> cream formulation incorporating a combined extract of frankincense resin, holding great promise for potential dermatological applications. The formulation has successfully eliminated commonly used ingredients such as alcohol, mineral oil, sodium lauryl sulfate, parabens, phthalates, and propylene glycol, making it a desirable option for individuals seeking all-natural skincare products free from these substances. The developed formulation showed favorable physicochemical characteristics and encouraging antioxidant activity, indicating its potential application as natural dermocosmetic preparation for skin protection against oxidative stress and photo-aging. However, further dermatological studies are warranted to evaluate the formulation&#x2019;s safety on the skin, specifically to assess its potential for causing skin irritation and erythema. While encouraging, the present work represents a preliminary step in the scientific validation of frankincense-based formulations. With its dual oil- and water-soluble bioactive fractions, frankincense resin provides a unique opportunity in the development of multifunctional, natural anti-aging creams. Future comprehensive studies shall provide valuable insights into the formulation&#x2019;s suitability for use in skincare products and ensure its compatibility with the skin, reinforcing its potential as a safe and effective ingredient.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>SJ contributed to conceptualization, methodology, investigation, data curation, and drafting of the manuscript. AS was involved in methodology, validation, resources, and critical review of the manuscript. SM performed formal analysis, data curation, visualization, and contributed to manuscript editing. WA provided supervision, project administration, and manuscript review. GK contributed to investigation, methodology, and formal analysis. MSA supported data curation, validation, and resource management. DS carried out visualization, software support, and data analysis. AJ assisted with investigation, laboratory work, and data collection. MYA contributed in methodology. HS supported investigation. TA contributed to formal analysis, visualization, and review. AN assisted with investigation, and data handling. NA supported in methodology. All authors contributed to the article and approved the submitted version.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>The authors gratefully acknowledge the funding of the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, through project number: RG24-M01.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The handling editor BW declared a past co-authorship with the author SJ.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Tawab</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Werz</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Schubert-Zsilavecz</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>
<italic>Boswellia serrata</italic>: an overall assessment of <italic>in vitro,</italic> preclinical, pharmacokinetic and clinical data</article-title>. <source>Clin Pharmacokinet</source> (<year>2011</year>) <volume>50</volume>(<issue>6</issue>):<fpage>349</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.2165/11586800-000000000-00000</pub-id>
<pub-id pub-id-type="pmid">21553931</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Saidi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rameshkumar</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Hisham</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Al-Kindy</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Composition and antibacterial activity of the essential oils of four commercial grades of Omani luban, the oleo-gum resin of Boswellia sacra FLUECK</article-title>. <source>Chem Biodivers</source> (<year>2012</year>) <volume>9</volume>(<issue>3</issue>):<fpage>615</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/cbdv.201100189</pub-id>
<pub-id pub-id-type="pmid">22422529</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marongiu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Piras</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Porcedda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tuveri</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Extraction of <italic>Santalum album</italic> and <italic>Boswellia carterii</italic> Birdw. volatile oil by supercritical carbon dioxide: influence of some process parameters</article-title>. <source>Flavour Frag J</source> (<year>2006</year>) <volume>4</volume>:<fpage>718</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/ffj.1718</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Yasiry</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Kiczorowska</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Frankincense--therapeutic properties</article-title>. <source>Postepy Hig Med Dosw (Online)</source> (<year>2016</year>) <volume>70</volume>:<fpage>380</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.5604/17322693.1200553</pub-id>
<pub-id pub-id-type="pmid">27117114</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>EL-Baz</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Hegazy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Kord</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Chemical composition of essential oil and <italic>in vitro</italic> antioxidant and antimicrobial activities of crude extracts of <italic>Commiphora myrrha</italic> resin</article-title>. <source>Ind Crop Prod</source> (<year>2014</year>) <volume>57</volume>:<fpage>10</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2014.03.017</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Amirshahrokhi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ajanii</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zadali</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Enayati</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Taxonomical investigation, chemical composition, traditional use in medicine, and pharmacological activities of <italic>Boswellia sacra</italic> flueck</article-title>. <source>Evid Based Complement Alternat Med</source> (<year>2022</year>) <volume>2022</volume>:<fpage>8779676</fpage>. <pub-id pub-id-type="doi">10.1155/2022/8779676</pub-id>
<pub-id pub-id-type="pmid">35222678</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assefa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dekebo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kassa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Habtu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fitwi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Redi-Abshiro</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Biophysical and chemical investigations of frankincense of <italic>Boswellia papyrifera</italic> from north and northwestern Ethiopia</article-title>. <source>J Chem Pharm Res</source> (<year>2012</year>) <volume>4</volume>:<fpage>1074</fpage>&#x2013;<lpage>89</lpage>.</mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baser</surname>
<given-names>KHC</given-names>
</name>
<name>
<surname>Demirci</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dekebo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dagne</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Essential oils of some <italic>Boswellia</italic> spp., Myrrh and Opopanax</article-title>. <source>Flavour Frag J</source> (<year>2003</year>) <volume>18</volume>(<issue>2</issue>):<fpage>153</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/ffj.1166</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ragab</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Abd El-Wahab</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Doghish</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Salama</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Eissa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Darwish</surname>
<given-names>SF</given-names>
</name>
</person-group>. <article-title>The journey of boswellic acids from synthesis to pharmacological activities</article-title>. <source>Naunyn Schmiedebergs Arch Pharmacol</source> (<year>2024</year>) <volume>397</volume>(<issue>3</issue>):<fpage>1477</fpage>&#x2013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-023-02725-w</pub-id>
<pub-id pub-id-type="pmid">37740772</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Harrath</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Al-Daghri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Alokail</surname>
<given-names>MS</given-names>
</name>
<etal/>
</person-group> <article-title>Ultrastructural and hormonal changes in rat cauda epididymal spermatozoa induced by <italic>Boswellia papyrifera</italic> and <italic>Boswellia carterii</italic>
</article-title>. <source>C R Biol</source> (<year>2014</year>) <volume>337</volume>(<issue>4</issue>):<fpage>250</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.crvi.2014.01.007</pub-id>
<pub-id pub-id-type="pmid">24702894</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fung</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wolley</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Suhail</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>HK</given-names>
</name>
</person-group>. <article-title>Cancer chemopreventive effects of Boswellia sacra gum resin hydrodistillates on invasive urothelial cell carcinoma: report of a case</article-title>. <source>Integr Cancer Ther</source> (<year>2017</year>) <volume>16</volume>(<issue>4</issue>):<fpage>605</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1177/1534735416664174</pub-id>
<pub-id pub-id-type="pmid">27531547</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rashan</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Phytochemical analysis and pharmaceutical applications of monoterpenoids present in the essential oil of <italic>Boswellia sacra</italic> (Omani Luban)</article-title>. <source>Adv Pharmacol Pharm Sci</source> (<year>2025</year>) <volume>2025</volume>:<fpage>3536898</fpage>. <pub-id pub-id-type="doi">10.1155/adpp/3536898</pub-id>
<pub-id pub-id-type="pmid">40040632</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banno</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Akihisa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yasukawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tokuda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri</article-title>. <source>J Ethnopharmacol</source> (<year>2006</year>) <volume>107</volume>(<issue>2</issue>):<fpage>249</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.03.006</pub-id>
<pub-id pub-id-type="pmid">16621377</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Parama</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Banik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bordoloi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Devi</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Thakur</surname>
<given-names>KK</given-names>
</name>
<etal/>
</person-group> <article-title>An update on pharmacological potential of boswellic acids against chronic diseases</article-title>. <source>Int J Mol Sci</source> (<year>2019</year>) <volume>20</volume>(<issue>17</issue>):<fpage>4101</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20174101</pub-id>
<pub-id pub-id-type="pmid">31443458</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotb</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>El-Shiekh</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Abd-Elsalam</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>El Sayed</surname>
<given-names>NSED</given-names>
</name>
<name>
<surname>El Tanbouly</surname>
<given-names>N</given-names>
</name>
<name>
<surname>El Senousy</surname>
<given-names>AS</given-names>
</name>
</person-group>. <article-title>Protective potential of frankincense essential oil and its loaded solid lipid nanoparticles against UVB-induced photodamage in rats <italic>via</italic> MAPK and PI3K/AKT signaling pathways; A promising anti-aging therapy</article-title>. <source>PLoS One</source> (<year>2023</year>) <volume>18</volume>(<issue>12</issue>):<fpage>e0294067</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0294067</pub-id>
<pub-id pub-id-type="pmid">38127865</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>TL</given-names>
</name>
</person-group>. <article-title>Biological activities of frankincense essential oil in human dermal fibroblasts</article-title>. <source>Biochim Open</source> (<year>2017</year>) <volume>4</volume>:<fpage>31</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopen.2017.01.003</pub-id>
<pub-id pub-id-type="pmid">29450138</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Togni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maramaldi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Di Pierro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Biondi</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis</article-title>. <source>Clin Cosmet Investig Dermatol</source> (<year>2014</year>) <volume>7</volume>:<fpage>321</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2147/CCID.S69240</pub-id>
<pub-id pub-id-type="pmid">25419153</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>XJ</given-names>
</name>
<etal/>
</person-group> <article-title>Acetyl-11-keto-&#x3b2;-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and <italic>in vitro</italic>
</article-title>. <source>Life Sci</source> (<year>2018</year>) <volume>207</volume>:<fpage>90</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2018.05.044</pub-id>
<pub-id pub-id-type="pmid">29859222</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shamraiz</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ur Rehman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Al-Shidhani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>HY</given-names>
</name>
<etal/>
</person-group> <article-title>Synthesis of new boswellic acid derivatives as potential antiproliferative agents</article-title>. <source>Nat Prod Res</source> (<year>2020</year>) <volume>34</volume>(<issue>13</issue>):<fpage>1845</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2018.1564295</pub-id>
<pub-id pub-id-type="pmid">30691289</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>IA</given-names>
</name>
</person-group>. <article-title>Anti-proliferative, pro-apoptotic, and chemosensitizing potential of 3-acetyl-11-keto-&#x3b2;-boswellic Acid (AKBA) against prostate cancer cells</article-title>. <source>Mol Biotechnol</source> (<year>2025</year>) <volume>67</volume>(<issue>2</issue>):<fpage>746</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1007/s12033-024-01089-7</pub-id>
<pub-id pub-id-type="pmid">38502429</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Um</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group> <article-title>Moisturizer in patients with inflammatory skin diseases</article-title>. <source>Medicina (Kaunas)</source> (<year>2022</year>) <volume>58</volume>(<issue>7</issue>):<fpage>888</fpage>. <pub-id pub-id-type="doi">10.3390/medicina58070888</pub-id>
<pub-id pub-id-type="pmid">35888607</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Al-Amin</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Russel</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kabir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhattacherjee</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hannan</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Phytochemical screening and evaluation of analgesic activity of Oroxylum indicum</article-title>. <source>Indian J Pharm Sci</source> (<year>2014</year>) <volume>76</volume>(<issue>6</issue>):<fpage>571</fpage>&#x2013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">25593396</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahimah</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Djunaedi</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Soeroto</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Bisri</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>The phytochemical screening, total phenolic contents and antioxidant activities <italic>in vitro</italic> of white oyster mushroom (Pleurotus ostreatus) preparations</article-title>. <source>Open Access Maced J Med Sci</source> (<year>2019</year>) <volume>7</volume>(<issue>15</issue>):<fpage>2404</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3889/oamjms.2019.741</pub-id>
<pub-id pub-id-type="pmid">31666837</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Occhipinti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Quantitative determination of 3-O-Acetyl-11-Keto-&#x3b2;Boswellic acid (AKBA) and other boswellic acids in Boswellia sacra flueck (syn. B. carteri birdw) and Boswellia serrata roxb</article-title>. <source>Molecules</source> (<year>2016</year>) <volume>21</volume>(<issue>10</issue>):<fpage>1329</fpage>. <pub-id pub-id-type="doi">10.3390/molecules21101329</pub-id>
<pub-id pub-id-type="pmid">27782055</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ciou</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YC</given-names>
</name>
</person-group>. <article-title>Foam properties and detergent abilities of the saponins from Camellia oleifera</article-title>. <source>Int J Mol Sci</source> (<year>2010</year>) <volume>11</volume>(<issue>11</issue>):<fpage>4417</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.3390/ijms11114417</pub-id>
<pub-id pub-id-type="pmid">21151446</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kancherla</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dhakshinamoothi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chitra</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Komaram</surname>
<given-names>RB</given-names>
</name>
</person-group>. <article-title>Preliminary analysis of phytoconstituents and evaluation of anthelminthic property of Cayratia auriculata <italic>(in vitro)</italic>
</article-title>. <source>Maedica (Bucur)</source> (<year>2019</year>) <volume>14</volume>(<issue>4</issue>):<fpage>350</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.26574/maedica.2019.14.4.350</pub-id>
<pub-id pub-id-type="pmid">32153665</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godlewska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pacyga</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Szumny</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szymczycha-Madeja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>We&#x142;na</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Michalak</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Methods for rapid screening of biologically active compounds present in plant-based extracts</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>20</issue>):<fpage>7094</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27207094</pub-id>
<pub-id pub-id-type="pmid">36296683</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahanayake</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Galappatty</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>HDSM</given-names>
</name>
<name>
<surname>Arawwawala</surname>
<given-names>LDAM</given-names>
</name>
</person-group>. <article-title>Comparative phytochemical analysis and antioxidant activities of Tamalakyadi decoction with its modified dosage forms</article-title>. <source>Evid Based Complement Alternat Med</source> (<year>2019</year>) <volume>2019</volume>:<fpage>6037137</fpage>. <pub-id pub-id-type="doi">10.1155/2019/6037137</pub-id>
<pub-id pub-id-type="pmid">31186663</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menachery</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Moni</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Khardali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elmobark</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Ali Albarqi</surname>
<given-names>AA</given-names>
</name>
<etal/>
</person-group> <article-title>Exploring the bioactive constituents, antibacterial, antioxidant potentialities of <italic>Aloe officinalis</italic> Forssk flower</article-title>. <source>Nat Prod Commun</source> (<year>2025</year>) <volume>20</volume>(<issue>1</issue>):<fpage>1934578X251314723</fpage>. <pub-id pub-id-type="doi">10.1177/1934578X251314723</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baliyan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Priyadarshini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vibhuti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>RP</given-names>
</name>
<etal/>
</person-group> <article-title>Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of <italic>Ficus religiosa</italic>
</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>4</issue>):<fpage>1326</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27041326</pub-id>
<pub-id pub-id-type="pmid">35209118</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bardaa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Makni</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boudaouara</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bardaa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ktari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hachicha</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Development and evaluation of the wound healing effect of a novel topical cream formula based on <italic>Ginkgo biloba</italic> extract on wounds in diabetic rats</article-title>. <source>Biomed Res Int</source> (<year>2021</year>) <volume>2021</volume>:<fpage>6474706</fpage>. <pub-id pub-id-type="doi">10.1155/2021/6474706</pub-id>
<pub-id pub-id-type="pmid">34692837</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Hosny</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Bukhary</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Fabrication and characterizations of pharmaceutical emulgel Co-Loaded with naproxen-eugenol for improved analgesic and anti-inflammatory effects</article-title>. <source>Gels</source> (<year>2022</year>) <volume>8</volume>(<issue>10</issue>):<fpage>608</fpage>. <pub-id pub-id-type="doi">10.3390/gels8100608</pub-id>
<pub-id pub-id-type="pmid">36286109</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharif</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Menaa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Menaa</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>BA</given-names>
</name>
<etal/>
</person-group> <article-title>Formulation and evaluation on human skin of a water-in-oil emulsion containing Muscat hamburg black grape seed extract</article-title>. <source>Int J Cosmet Sci</source> (<year>2015</year>) <volume>37</volume>(<issue>2</issue>):<fpage>253</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/ics.12184.16</pub-id>
<pub-id pub-id-type="pmid">25402429</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhtar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Menaa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Javed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Tocopherol succinate-loaded ethosomal gel synthesized by cold method technique: deeper biophysical characterizations for translational application on human skin</article-title>. <source>J Cosmet Dermatol</source> (<year>2024</year>) <volume>23</volume>(<issue>3</issue>):<fpage>1015</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.16054</pub-id>
<pub-id pub-id-type="pmid">38268219</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalak</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Plant extracts as skin care and therapeutic agents</article-title>. <source>Int J Mol Sci</source> (<year>2023</year>) <volume>24</volume>(<issue>20</issue>):<fpage>15444</fpage>. <pub-id pub-id-type="doi">10.3390/ijms242015444</pub-id>
<pub-id pub-id-type="pmid">37895122</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rajani</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Semwal</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Semwal</surname>
<given-names>DK</given-names>
</name>
</person-group>. <article-title>Formulation and evaluation of polyherbal cream and lotion for the treatment of psoriasis-induced secondary infections</article-title>. <source>Curr Rev Clin Exp Pharmacol</source> (<year>2021</year>) <volume>16</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.2174/1574884714666191017111218</pub-id>
<pub-id pub-id-type="pmid">31622222</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahshawat</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Saraf</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saraf</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Preparation and characterization of herbal creams for improvement of skin viscoelastic properties</article-title>. <source>Int J Cosmet Sci</source> (<year>2008</year>) <volume>30</volume>(<issue>3</issue>):<fpage>183</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-2494.2008.00442.x</pub-id>
<pub-id pub-id-type="pmid">18452435</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amiri</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Mohammadzadeh</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Yazdi</surname>
<given-names>MET</given-names>
</name>
<name>
<surname>Barani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rahdar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kyzas</surname>
<given-names>GZ</given-names>
</name>
</person-group>. <article-title>Plant-based gums and mucilages applications in pharmacology and nanomedicine: a review</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>(<issue>6</issue>):<fpage>1770</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26061770</pub-id>
<pub-id pub-id-type="pmid">33809917</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moldovan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lahmar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bogdan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>P&#x103;r&#x103;uan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tomu&#x163;&#x103;</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cri&#x15f;an</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Formulation and evaluation of a water-in-oil cream containing herbal active ingredients and ferulic acid</article-title>. <source>Clujul Med</source> (<year>2017</year>) <volume>90</volume>(<issue>2</issue>):<fpage>212</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.15386/cjmed-668</pub-id>
<pub-id pub-id-type="pmid">28559707</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nasr</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Abdel-Ghany</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arneth</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sabit</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Anti-tumor potential of frankincense essential oil and its nano-formulation in breast cancer: an <italic>in vivo</italic> and <italic>in vitro</italic> study</article-title>. <source>Pharmaceutics</source> (<year>2025</year>) <volume>17</volume>(<issue>4</issue>):<fpage>426</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics17040426</pub-id>
<pub-id pub-id-type="pmid">40284420</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meziane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zraibi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Albusayr</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bitari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oussaid</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammouti</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Rosmarinus officinalis Linn.: unveiling its multifaceted nature in nutrition, diverse applications, and advanced extraction methods</article-title>. <source>J Umm Al-qura Univ Appl Sci</source> (<year>2025</year>) <volume>11</volume>:<fpage>9</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/s43994-024-00144-y</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diass</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oualdi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Benabbas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ouabane</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hammouti</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Use of essential oils for the treatment of Fusarium oxysporum f. sp. Albedinis: Chemical profile, <italic>in vitro</italic> antifungal activity, and <italic>in silico</italic> investigation by molecular docking study</article-title>. <source>Curr Chem Biol</source> (<year>2024</year>) <volume>18</volume>(<issue>4</issue>):<fpage>193</fpage>&#x2013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.2174/0122127968296919240926095348</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venkatesan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sivadasan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Abderrahmen</surname>
<given-names>AWM</given-names>
</name>
<name>
<surname>Gayasuddin Mouid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goyal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bansal</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Protective effects of frankincense oil on wound healing: downregulating caspase-3 expression to facilitate the transition from the inflammatory to proliferative phase</article-title>. <source>Pharmaceuticals (Basel)</source> (<year>2025</year>) <volume>18</volume>(<issue>3</issue>):<fpage>407</fpage>. <pub-id pub-id-type="doi">10.3390/ph18030407</pub-id>
<pub-id pub-id-type="pmid">40143183</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halim</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Csuk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Al-Rawahi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Harrasi</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Diterpenoids and triterpenoids from frankincense are excellent anti-psoriatic agents: an <italic>in silico</italic> approach</article-title>. <source>Front Chem</source> (<year>2020</year>) <volume>8</volume>:<fpage>486</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2020.00486</pub-id>
<pub-id pub-id-type="pmid">32671018</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javed</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mangla</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Salawi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sultan</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Almoshari</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ahsan</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Essential oils as dermocosmetic agents, their mechanism of action and nanolipidic formulations for maximized skincare</article-title>. <source>Cosmetics</source> (<year>2024</year>) <volume>11</volume>(<issue>6</issue>):<fpage>210</fpage>. <pub-id pub-id-type="doi">10.3390/cosmetics11060210</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maloh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Natarelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gunt</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Tristani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sivamani</surname>
<given-names>RK</given-names>
</name>
</person-group>. <article-title>A review of the use of beeswax in skincare</article-title>. <source>J Cosmet Dermatol</source> (<year>2023</year>) <volume>22</volume>(<issue>8</issue>):<fpage>2166</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.15718</pub-id>
<pub-id pub-id-type="pmid">36999457</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavla&#x10d;kov&#xe1;</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Egner</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Slav&#xed;k</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mokrej&#x161;</surname>
<given-names>P</given-names>
</name>
<name>
<surname>G&#xe1;l</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Hydration and barrier potential of cosmetic matrices with bee products</article-title>. <source>Molecules</source> (<year>2020</year>) <volume>25</volume>(<issue>11</issue>):<fpage>2510</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25112510</pub-id>
<pub-id pub-id-type="pmid">32481539</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Przyby&#x142;ek</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Karpi&#x144;ski</surname>
<given-names>TM</given-names>
</name>
</person-group>. <article-title>Antibacterial properties of propolis</article-title>. <source>Molecules</source> (<year>2019</year>) <volume>24</volume>(<issue>11</issue>):<fpage>2047</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24112047</pub-id>
<pub-id pub-id-type="pmid">31146392</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurek-G&#xf3;recka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rzepecka-Stojko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>G&#xf3;recki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stojko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sosada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Swierczek-Zieba</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Structure and antioxidant activity of polyphenols derived from propolis</article-title>. <source>Molecules</source> (<year>2013</year>) <volume>19</volume>(<issue>1</issue>):<fpage>78</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.3390/molecules19010078</pub-id>
<pub-id pub-id-type="pmid">24362627</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagh</surname>
<given-names>VD</given-names>
</name>
</person-group>. <article-title>Propolis: a wonder bees product and its pharmacological potentials</article-title>. <source>Adv Pharmacol Sci</source> (<year>2013</year>) <volume>2013</volume>:<fpage>308249</fpage>. <pub-id pub-id-type="doi">10.1155/2013/308249</pub-id>
<pub-id pub-id-type="pmid">24382957</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>Z</given-names>
</name>
</person-group>. <article-title>The uses and properties of almond oil</article-title>. <source>Complement Ther Clin Pract</source> (<year>2010</year>) <volume>16</volume>(<issue>1</issue>):<fpage>10</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctcp.2009.06.015</pub-id>
<pub-id pub-id-type="pmid">20129403</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boskabady</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Shafei</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Saberi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Amini</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Pharmacological effects of <italic>Rosa damascena</italic>
</article-title>. <source>Iran J Basic Med Sci</source> (<year>2011</year>) <volume>14</volume>(<issue>4</issue>):<fpage>295</fpage>&#x2013;<lpage>307</lpage>.<pub-id pub-id-type="pmid">23493250</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Triterpenoid resinous metabolites from the genus boswellia: pharmacological activities and potential species-identifying properties</article-title>. <source>Chem Cent J</source> (<year>2013</year>) <volume>7</volume>(<issue>1</issue>):<fpage>153</fpage>. <pub-id pub-id-type="doi">10.1186/1752-153X-7-153</pub-id>
<pub-id pub-id-type="pmid">24028654</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddiqui</surname>
<given-names>MZ</given-names>
</name>
</person-group>. <article-title>
<italic>Boswellia serrata</italic>, a potential antiinflammatory agent: an overview</article-title>. <source>Indian J Pharm Sci</source> (<year>2011</year>) <volume>73</volume>(<issue>3</issue>):<fpage>255</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.4103/0250-474X.93507</pub-id>
<pub-id pub-id-type="pmid">22457547</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida-da-Silva</surname>
<given-names>CLC</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chang-Chien</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Qoronfleh</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Ojcius</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of frankincense compounds on infection, inflammation, and oral health</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>13</issue>):<fpage>4174</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27134174</pub-id>
<pub-id pub-id-type="pmid">35807419</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>XR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Seeing the unseen of the combination of two natural resins, frankincense and myrrh: changes in chemical constituents and pharmacological activities</article-title>. <source>Molecules</source> (<year>2019</year>) <volume>24</volume>(<issue>17</issue>):<fpage>3076</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24173076</pub-id>
<pub-id pub-id-type="pmid">31450584</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borotov&#xe1;</surname>
<given-names>P</given-names>
</name>
<name>
<surname>&#x10c;mikov&#xe1;</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Galovi&#x10d;ov&#xe1;</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vukovic</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Vukic</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Tvrd&#xe1;</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Antioxidant, antimicrobial, and anti-insect properties of <italic>Boswellia carterii</italic> essential oil for food preservation improvement</article-title>. <source>Horticulturae</source> (<year>2023</year>) <volume>9</volume>(<issue>3</issue>):<fpage>333</fpage>. <pub-id pub-id-type="doi">10.3390/horticulturae9030333</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arabshahi-Delouee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zinoviadou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Galanakis</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Antioxidant properties of various solvent extracts of Indian frankincense (<italic>Boswellia serrata</italic>) oleogum resin</article-title>. <source>Iranian Food Sci Technol Res J</source> (<year>2017</year>) <volume>13</volume>(<issue>3</issue>):<fpage>28</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.22067/ifstrj.v1396i3.61520</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popko</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gorska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stelmaszczyk-Emmel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Plywaczewski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stoklosa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gorecka</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Proinflammatory cytokines Il-6 and TNF-&#x3b1; and the development of inflammation in obese subjects</article-title>. <source>Eur J Med Res</source> (<year>2010</year>) <volume>15</volume>(<issue>Suppl. 2</issue>):<fpage>120</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1186/2047-783x-15-s2-120</pub-id>
<pub-id pub-id-type="pmid">21147638</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkumar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Presley</surname>
<given-names>SID</given-names>
</name>
<name>
<surname>Govindaraj</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Girigoswami</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Meenambigai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Deepak</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Biomedical prowess of Clitoria mariana (L.) flower methanolic extract: a comprehensive <italic>in vitro</italic>, <italic>Ex Vivo</italic>, and <italic>in vivo</italic> evaluation</article-title>. <source>Chem Biodivers</source> (<year>2025</year>) <volume>22</volume>(<issue>12</issue>):<fpage>e01051</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202501051</pub-id>
<pub-id pub-id-type="pmid">40773726</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1976642/overview">Bwalya Angel Witika</ext-link>, Sefako Makgatho Health Sciences University, South Africa</p>
</fn>
</fn-group>
</back>
</article>